Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter

T. Ignacio Montoya, Jesus F. Acevedo, Benjamin Smith, Patrick W. Keller, Joseph L. Sailors, Liping Tang, R. Ann Word, Clifford Y. Wai

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To evaluate the effect of myogenic stem cell-laden hydrogel scaffold on contractile function and histomorphology of the external anal sphincter (EAS) after transection without repair. Methods: Eighty female rats underwent anal sphincter transection without repair. After 2 weeks, animals were injected at the transection site with: nothing (non-repaired control, NRC group); a polyethylene glycol-based hydrogel matrix scaffold combined with phosphate-buffered saline (PBS/hydrogel group); a hydrogel matrix scaffold combined with myogenic stem cells (stem cell/hydrogel group): or type I collagen (collagen) group. 4 (n = 40) or 12 (n = 40) weeks later, the anal sphincter complexes were dissected out and analyzed for contractile function, disruption, and striated muscle volume. Time-matched unoperated controls (UOC) were utilized for each of the two time points (n = 20). Results: After 4 weeks, maximal electrical field-stimulated (EFS) contractions were significantly decreased in all four non-repaired treatment groups compared with UOC. However, EFS-stimulated contractions, tetanic force generation, and twitch tension were improved in non-repaired EAS injected with stem cell/hydrogel group relative to the NRC, PBS/hydrogel, or collagen groups. NRC and sphincters injected with PBS/hydrogel deteriorated further by 12 weeks, while those receiving stem cell/hydrogel maintained improved contractile function at varying frequencies and voltages. Striated muscle volume increased from 4 to 12 weeks for PBS/hydrogel and stem cell/hydrogel animals. At 12 weeks, stem cell/hydrogel animals had greater sphincter striated muscle volumes compared with all other treatment groups. Conclusion: In this animal model, sustained improvement of contractile responses in non-repaired EAS treated with biogel scaffold and myogenic stem cells suggests that a biologically compatible matrix may facilitate stem cell survival, differentiation, or function leading to recovery of contractile function even after persistent disruption.

Original languageEnglish (US)
Pages (from-to)893-904
Number of pages12
JournalInternational Urogynecology Journal and Pelvic Floor Dysfunction
Volume26
Issue number6
DOIs
StatePublished - Feb 3 2015

Fingerprint

Hydrogel
Anal Canal
Wound Healing
Stem Cells
Striated Muscle
Collagen
Recovery of Function
Collagen Type I
Cell Differentiation
Cell Survival
Animal Models
Phosphates

Keywords

  • Biogel
  • Bioscaffold
  • Physiology
  • Wound healing

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology

Cite this

Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter. / Montoya, T. Ignacio; Acevedo, Jesus F.; Smith, Benjamin; Keller, Patrick W.; Sailors, Joseph L.; Tang, Liping; Word, R. Ann; Wai, Clifford Y.

In: International Urogynecology Journal and Pelvic Floor Dysfunction, Vol. 26, No. 6, 03.02.2015, p. 893-904.

Research output: Contribution to journalArticle

@article{1cf0b0ff87874281b4c36d3008c618ae,
title = "Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter",
abstract = "Objective: To evaluate the effect of myogenic stem cell-laden hydrogel scaffold on contractile function and histomorphology of the external anal sphincter (EAS) after transection without repair. Methods: Eighty female rats underwent anal sphincter transection without repair. After 2 weeks, animals were injected at the transection site with: nothing (non-repaired control, NRC group); a polyethylene glycol-based hydrogel matrix scaffold combined with phosphate-buffered saline (PBS/hydrogel group); a hydrogel matrix scaffold combined with myogenic stem cells (stem cell/hydrogel group): or type I collagen (collagen) group. 4 (n = 40) or 12 (n = 40) weeks later, the anal sphincter complexes were dissected out and analyzed for contractile function, disruption, and striated muscle volume. Time-matched unoperated controls (UOC) were utilized for each of the two time points (n = 20). Results: After 4 weeks, maximal electrical field-stimulated (EFS) contractions were significantly decreased in all four non-repaired treatment groups compared with UOC. However, EFS-stimulated contractions, tetanic force generation, and twitch tension were improved in non-repaired EAS injected with stem cell/hydrogel group relative to the NRC, PBS/hydrogel, or collagen groups. NRC and sphincters injected with PBS/hydrogel deteriorated further by 12 weeks, while those receiving stem cell/hydrogel maintained improved contractile function at varying frequencies and voltages. Striated muscle volume increased from 4 to 12 weeks for PBS/hydrogel and stem cell/hydrogel animals. At 12 weeks, stem cell/hydrogel animals had greater sphincter striated muscle volumes compared with all other treatment groups. Conclusion: In this animal model, sustained improvement of contractile responses in non-repaired EAS treated with biogel scaffold and myogenic stem cells suggests that a biologically compatible matrix may facilitate stem cell survival, differentiation, or function leading to recovery of contractile function even after persistent disruption.",
keywords = "Biogel, Bioscaffold, Physiology, Wound healing",
author = "Montoya, {T. Ignacio} and Acevedo, {Jesus F.} and Benjamin Smith and Keller, {Patrick W.} and Sailors, {Joseph L.} and Liping Tang and Word, {R. Ann} and Wai, {Clifford Y.}",
year = "2015",
month = "2",
day = "3",
doi = "10.1007/s00192-014-2620-6",
language = "English (US)",
volume = "26",
pages = "893--904",
journal = "International Urogynecology Journal and Pelvic Floor Dysfunction",
issn = "0937-3462",
publisher = "Springer London",
number = "6",

}

TY - JOUR

T1 - Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter

AU - Montoya, T. Ignacio

AU - Acevedo, Jesus F.

AU - Smith, Benjamin

AU - Keller, Patrick W.

AU - Sailors, Joseph L.

AU - Tang, Liping

AU - Word, R. Ann

AU - Wai, Clifford Y.

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Objective: To evaluate the effect of myogenic stem cell-laden hydrogel scaffold on contractile function and histomorphology of the external anal sphincter (EAS) after transection without repair. Methods: Eighty female rats underwent anal sphincter transection without repair. After 2 weeks, animals were injected at the transection site with: nothing (non-repaired control, NRC group); a polyethylene glycol-based hydrogel matrix scaffold combined with phosphate-buffered saline (PBS/hydrogel group); a hydrogel matrix scaffold combined with myogenic stem cells (stem cell/hydrogel group): or type I collagen (collagen) group. 4 (n = 40) or 12 (n = 40) weeks later, the anal sphincter complexes were dissected out and analyzed for contractile function, disruption, and striated muscle volume. Time-matched unoperated controls (UOC) were utilized for each of the two time points (n = 20). Results: After 4 weeks, maximal electrical field-stimulated (EFS) contractions were significantly decreased in all four non-repaired treatment groups compared with UOC. However, EFS-stimulated contractions, tetanic force generation, and twitch tension were improved in non-repaired EAS injected with stem cell/hydrogel group relative to the NRC, PBS/hydrogel, or collagen groups. NRC and sphincters injected with PBS/hydrogel deteriorated further by 12 weeks, while those receiving stem cell/hydrogel maintained improved contractile function at varying frequencies and voltages. Striated muscle volume increased from 4 to 12 weeks for PBS/hydrogel and stem cell/hydrogel animals. At 12 weeks, stem cell/hydrogel animals had greater sphincter striated muscle volumes compared with all other treatment groups. Conclusion: In this animal model, sustained improvement of contractile responses in non-repaired EAS treated with biogel scaffold and myogenic stem cells suggests that a biologically compatible matrix may facilitate stem cell survival, differentiation, or function leading to recovery of contractile function even after persistent disruption.

AB - Objective: To evaluate the effect of myogenic stem cell-laden hydrogel scaffold on contractile function and histomorphology of the external anal sphincter (EAS) after transection without repair. Methods: Eighty female rats underwent anal sphincter transection without repair. After 2 weeks, animals were injected at the transection site with: nothing (non-repaired control, NRC group); a polyethylene glycol-based hydrogel matrix scaffold combined with phosphate-buffered saline (PBS/hydrogel group); a hydrogel matrix scaffold combined with myogenic stem cells (stem cell/hydrogel group): or type I collagen (collagen) group. 4 (n = 40) or 12 (n = 40) weeks later, the anal sphincter complexes were dissected out and analyzed for contractile function, disruption, and striated muscle volume. Time-matched unoperated controls (UOC) were utilized for each of the two time points (n = 20). Results: After 4 weeks, maximal electrical field-stimulated (EFS) contractions were significantly decreased in all four non-repaired treatment groups compared with UOC. However, EFS-stimulated contractions, tetanic force generation, and twitch tension were improved in non-repaired EAS injected with stem cell/hydrogel group relative to the NRC, PBS/hydrogel, or collagen groups. NRC and sphincters injected with PBS/hydrogel deteriorated further by 12 weeks, while those receiving stem cell/hydrogel maintained improved contractile function at varying frequencies and voltages. Striated muscle volume increased from 4 to 12 weeks for PBS/hydrogel and stem cell/hydrogel animals. At 12 weeks, stem cell/hydrogel animals had greater sphincter striated muscle volumes compared with all other treatment groups. Conclusion: In this animal model, sustained improvement of contractile responses in non-repaired EAS treated with biogel scaffold and myogenic stem cells suggests that a biologically compatible matrix may facilitate stem cell survival, differentiation, or function leading to recovery of contractile function even after persistent disruption.

KW - Biogel

KW - Bioscaffold

KW - Physiology

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=84929834230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929834230&partnerID=8YFLogxK

U2 - 10.1007/s00192-014-2620-6

DO - 10.1007/s00192-014-2620-6

M3 - Article

VL - 26

SP - 893

EP - 904

JO - International Urogynecology Journal and Pelvic Floor Dysfunction

JF - International Urogynecology Journal and Pelvic Floor Dysfunction

SN - 0937-3462

IS - 6

ER -